Abstract
End-stage systolic heart failure is an increasingly common problem in elderly patients and is associated with high cost, poor quality of life, and poor outcomes. Mechanical circulatory support is a promising therapy as both a bridge to transplantation and destination therapy. Elderly patients are frequently ineligible for heart transplantation because of their age and comorbidities, and the application of mechanical circulatory support for destination therapy in this population is not well defined. A review of the literature was undertaken to better characterize our experience to date with mechanical circulatory support in older heart failure populations. Mechanical circulatory support is being employed increasingly for destination therapy indications in older patients. The newer continuous flow devices appear to have disproportionate advantage in elderly patients, which has translated into marked improvement in 1- and 2-year survival. The rational implementation of MCS devices in elderly heart failure patients needs to focus on (1) continuous flow devices that appear to have particular benefit in this population, (2) extensive pre-MCS assessment including variables relating to frailty, and (3) intervening before these patients develop cardiogenic shock. More data are needed on the cost-benefit analysis of routine use of CF devices as destination therapy in elderly patients with heart failure.
Similar content being viewed by others
References
Hunt SA (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 46(6):e1–e82
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation 119(14):e391–e479. doi:10.1161/CIRCULATIONAHA.109.192065
Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M (2006) Listing criteria for heart transplantation: international society for heart and lung transplantation guidelines for the care of cardiac transplant candidates–2006. J Heart Lung Transplant 25(9):1024–1042. doi:10.1016/j.healun.2006.06.008
Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB (2011) Third INTERMACS annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant 30(2):115–123. doi:10.1016/j.healun.2010.12.001
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL (2001) Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345(20):1435–1443
Forman DE, Rich MW, Alexander KP, Zieman S, Maurer MS, Najjar SS, Cleveland JC, Jr., Krumholz HM, Wenger NK (2011) Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol 57(18):1801–1810. doi:10.1016/j.jacc.2011.02.014
Ravaglia G, Forti P, Lucicesare A, Pisacane N, Rietti E, Patterson C (2008) Development of an easy prognostic score for frailty outcomes in the aged. Age Ageing 37(2):161–166. doi:10.1093/ageing/afm195
Huang R, Deng M, Rogers JG, Howser R, Portner PM, Pierson RN 3rd, Butler J (2006) Effect of age on outcomes after left ventricular assist device placement. Transplant Proc 38(5):1496–1498. doi:10.1016/j.transproceed.2006.02.115
Kwon MH, Moriguchi JD, Ardehali A, Jocson R, Marelli D, Laks H, Shemin RJ, Esmailian F (2009) Use of ventricular assist device as a bridge to cardiac transplantation: impact of age and other determinants on outcomes. Tex Heart Inst J 36(3):214–219
Stepanenko A, Potapov EV, Jurmann B, Lehmkuhl HB, Dandel M, Siniawski H, Drews T, Hennig E, Kaufmann F, Jurmann MJ, Weng Y, Pasic M, Hetzer R, Krabatsch T (2010) Outcomes of elective versus emergent permanent mechanical circulatory support in the elderly: a single-center experience. J Heart Lung Transplant 29(1):61–65. doi:10.1016/j.healun.2009.10.008
Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, Zuckermann AO, Wieselthaler GM (2009) Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation. J Heart Lung Transplant 28(4):367–372. doi:10.1016/j.healun.2009.01.008
Deng MC, Loebe M, El-Banayosy A, Gronda E, Jansen PG, Vigano M, Wieselthaler GM, Reichart B, Vitali E, Pavie A, Mesana T, Loisance DY, Wheeldon DR, Portner PM (2001) Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 103(2):231–237
El-Banayosy A, Arusoglu L, Kizner L, Tenderich G, Boethig D, Minami K, Korfer R (2000) Predictors of survival in patients bridged to transplantation with the thoratec VAD device: a single-center retrospective study on more than 100 patients. J Heart Lung Transplant 19(10):964–968. doi:S1053-2498(00)00174-1
Jurmann MJ, Weng Y, Drews T, Pasic M, Hennig E, Hetzer R (2004) Permanent mechanical circulatory support in patients of advanced age. Eur J Cardiothorac Surg 25(4):610–618. doi:10.1016/j.ejcts.2004.01.017
Adamson RM, Stahovich M, Chillcott S, Baradarian S, Chammas J, Jaski B, Hoagland P, Dembitsky W (2011) Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience. J Am Coll Cardiol 57(25):2487–2495. doi:10.1016/j.jacc.2011.01.043
Dang NC, Topkara VK, Kim BT, Mercando ML, Kay J, Naka Y (2005) Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation. J Thorac Cardiovasc Surg 130(5):1302–1309. doi:10.1016/j.jtcvs.2005.07.017
Goldstein DJ, Beauford RB (2003) Left ventricular assist devices and bleeding: adding insult to injury. Ann Thorac Surg 75(6 Suppl):S42–S47
Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V, 3rd, Sharma R, Wu J, Arepally G, Bowles D, Rogers J, Villamizar-Ortiz N (2010) Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 90(4):1263–1269; discussion 1269. doi:10.1016/j.athoracsur.2010.04.099
Froom P, Miron E, Barak M (2003) Oral anticoagulants in the elderly. Br J Haematol 120(3):526–528. doi:4110
Beyth RJ, Quinn LM, Landefeld CS (1998) Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 105(2):91–99
Delaney JA, Opatrny L, Brophy JM, Suissa S (2007) Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 177(4):347–351. doi:10.1503/cmaj.070186
Limdi NA, Beasley TM, Baird MF, Goldstein JA, McGwin G, Arnett DK, Acton RT, Allon M (2009) Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol 20(4):912–921. doi:10.1681/ASN.2008070802
Heverly DN, Prayson RA (2001) Neuropathology associated with ventricular assist devices: an autopsy series of 33 patients. Ann Diagn Pathol 5(2):67–73. doi:10.1053/adpa.2001.23019
Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, Frazier OH, Heatley G, Farrar DJ, John R (2009) Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 28(9):881–887. doi:10.1016/j.healun.2009.05.018
Litmathe J, Boeken U, Feindt P, Marktanner R, Gams E (2004) Mechanical assist devices as bridging systems to transplantation: a current review, possible risks, and perspectives. Transplant Proc 36(10):3123–3128. doi:10.1016/j.transproceed.2004.10.082
Isao Yada YM (2009) Pulsatile flow versus nonpulsatile flow. J artif organ 2:1–2
Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH (2007) Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357(9):885–896. doi:10.1056/NEJMoa067758
Thalmann M, Schima H, Wieselthaler G, Wolner E (2005) Physiology of continuous blood flow in recipients of rotary cardiac assist devices. J Heart Lung Transplant 24(3):237–245. doi:10.1016/j.healun.2004.04.018
Drews T, Stepanenko A, Dandel M, Buz S, Lehmkuhl HB, Hetzer R (2010) Mechanical circulatory support in patients of advanced age. Eur J Heart Fail 12(9):990–994. doi:10.1093/eurjhf/hfq076
Clegg AJ, Scott DA, Loveman E, Colquitt JL, Royle P, Bryant J (2006) Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation. Eur Heart J 27(24):2929–2938
Hall JL, Fermin DR, Birks EJ, Barton PJ, Slaughter M, Eckman P, Baba HA, Wohlschlaeger J, Miller LW (2011) Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol 57(6):641–652. doi:10.1016/j.jacc.2010.11.010
Jugdutt BI (2009) Current and novel cardiac support therapies. Curr Heart Fail Rep 6(1):19–27
Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, Kormos R, Naftel DC, Kirklin JK, Taylor DO (2005) Mechanical circulatory support device database of the international society for heart and lung transplantation: third annual report–2005. J Heart Lung Transplant 24(9):1182–1187
Dandel M, Weng Y, Siniawski H, Potapov E, Lehmkuhl HB, Hetzer R (2005) Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 112(9 Suppl):I37–I45
Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, Pagani FD, Miller LW, Margulies K, McRee S, Frazier OH, Torre-Amione G (2007) Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD working group. Circulation 115(19):2497–2505
Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, Poirier VL, Dasse KA (2001) Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 122(6):1186–1195. doi:10.1067/mtc.2001.118274
Acknowledgments
This work was supported in part by grant # IAP-99,003 from the Canadian Institutes of Health Research, Ottawa, Ontario. We thank Catherine Jugdutt for assistance.
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Butler, C.R., Jugdutt, B.I. Mechanical circulatory support for elderly heart failure patients. Heart Fail Rev 17, 663–669 (2012). https://doi.org/10.1007/s10741-012-9298-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-012-9298-y